| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5871586 | Clinical Nutrition | 2011 | 6 Pages |
Abstract
PS therapy appears to be of little value to MetS patients, likely due to its reduced intestinal cholesterol absorption. The efficacy of PS as hypocholesterolaemic agents is thus limited.
Keywords
NCEP-ATP IIINational Cholesterol Education Program-Adult Treatment Panel IIILDLchsCRPHDLCHOMA-IRapoapolipoproteinHomeostasis model assessment-insulin resistanceTriglyceridesMetabolic syndromebody mass indexBMICoefficient of VariationBlood pressurePhytosterolshigh-density lipoprotein cholesterolMETShigh-sensitivity C-reactive proteinLipid profileLow-density lipoprotein cholesterol
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Antonio Hernández-Mijares, Celia Bañuls, Ana Jover, Eva Solá, Lorena Bellod, Maria L. MartÃnez-Triguero, Maria J. Lagarda, VÃctor M. VÃctor, Milagros Rocha,